Global equitable access to COVID-19 vaccines estimated to generate economic benefits of at least US$ 153 billion in 2020–21, and US$ 466 billion by 2025, in 10 major economies, according to new report by the Eurasia Group
The FINANCIAL -- As world leaders gather virtually at the Special Session of the General Assembly in response to the COVID-19 ...
